Drug approval (and rejection) highlights from 2012

Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines. Read more
Posted by Elie Dolgin | Categories: Drugs, drugs and more drugs
Another year, another round of approvals, mixed reviews and high-profile failures. We look back on which medicines made the headlines. Read more